Skip to content
← Back to this collection

PUBLICATIONS · 31532724

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Jan 1
First author
Khodadoust MS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Khodadoust MS
      type
      Author
    2. name
      Rook AH
      type
      Author
    3. name
      Porcu P
      type
      Author
    4. name
      Foss F
      type
      Author
    5. name
      Moskowitz AJ
      type
      Author
    6. name
      Shustov A
      type
      Author
    7. name
      Shanbhag S
      type
      Author
    8. name
      Sokol L
      type
      Author
    9. name
      Fling SP
      type
      Author
    10. name
      Ramchurren N
      type
      Author
    11. name
      Pierce R
      type
      Author
    12. name
      Davis A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Khodadoust MS
      type
      Author
    2. name
      Rook AH
      type
      Author
    3. name
      Porcu P
      type
      Author
    4. name
      Foss F
      type
      Author
    5. name
      Moskowitz AJ
      type
      Author
    6. name
      Shustov A
      type
      Author
    7. name
      Shanbhag S
      type
      Author
    8. name
      Sokol L
      type
      Author
    9. name
      Fling SP
      type
      Author
    10. name
      Ramchurren N
      type
      Author
    11. name
      Pierce R
      type
      Author
    12. name
      Davis A
      type
      Author
    bibliography ids
    1. nci-bib-db33b53a75114e2378620e42
    book metadata
    content sha256
    7c60066888650e086696ed179730fd0620a059739b3815c48d66329cae182c58
    document type
    citation
    dois
    1. 10.1200/JCO.19.01056
    electronic publication date
    display
    2019 Sep 18
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31532724
    immutable id
    pubmed:31532724@7c60066888650e086696ed179730fd0620a059739b3815c48d66329cae182c58
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    1
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    20-28
    volume
    38
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31532724
      provenance
      batch id
      23ffe1e2a9e160b6dca0
      provider
      NCBI PubMed ESummary
      record sha256
      8d9e8c7a2ff31387d32fc578c31050e25dc936a10e89bbe11c7a6f1b68cd1452
      response sha256
      d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
      retrieved at
      2026-09-09T23:47:44.690737+00:00
      publication date
      display
      2020 Jan 1
      precision
      day
      year
      2020
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31532724/
      title
      Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.

      Preserved source evidence · Not medical advice